300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Social Impact
Email
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
Biotechnology
eSports
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Recruiting
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Web3
Wine and Spirits
Music
Art
Medical
Real Estate
Sporting Goods
Theatre
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Internet
Community
Media (Entertainment)
Mobile Advertising
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Malawi
Liberia
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Costa Rica
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mauritius
Mozambique
Namibia
Nicaragua
Panama
Uzbekistan
Serbia
New Zealand
Australia
Morocco
Saudi Arabia
Guatemala
Sri Lanka
Jamaica
Kazakhstan
Switzerland
Venezuela
Cayman Islands
Myanmar
Turkey
Uruguay
Uganda
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Iraq
Ghana
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
El Salvador
Senegal
Sierra Leone
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Barbados
Belgium
Angola
Cyprus
Jordan
Azerbaijan
Ethiopia
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Ecuador
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Grenada
Finland
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Momi Karako

Partner @ Pontifax

Momi Karako is a psrtner at Pontifax Ventures.

Total investments:
2
Last investment:
Lead investor:
100%

Last updated:

Industries Momi Karako invests in

BiotechnologyHealth CareTherapeuticsPharmaceutical

Stages Momi Karako invests in

Post-IPO DebtDebt Financing

Countries Momi Karako invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 2 (100%)
  • Health Care 1 (50%)
  • Therapeutics 1 (50%)
  • Pharmaceutical 1 (50%)

Stage

  • Post-IPO Debt 1 (50%)
  • Debt Financing 1 (50%)

Investments

CompanyDescriptionRoundLinks
Opiant Pharmaceuticals, with its team of addiction experts, is headquartered in Santa Monica, California. The Company, formerly known as Lightlake Therapeutics, was founded in 2009 by the late Dr. David Sinclair based on his pioneering research demonstrating that opioid antagonists could be used as a symptom-driven treatment for alcoholism $50M / Debt Financing / Oct 12, 2020
Allena Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program forthe treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. $25M / Post-IPO Debt / Sep 30, 2020
Pontifax

About Pontifax

VC Fund · Herzliya, Israel

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Pontifax Contacts

NameEmailPhoneSocials
Ohad Hammer
Ohad Hammer Partner
Ran Nussbaum
Ran Nussbaum Managing Partner and Co-Founder
Tomer Kariv
Tomer Kariv Co-Founder and Chief Executive Officer
Momi Karako Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 4 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Social Impact
Email
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
Biotechnology
eSports
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Recruiting
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Web3
Wine and Spirits
Music
Art
Medical
Real Estate
Sporting Goods
Theatre
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Internet
Community
Media (Entertainment)
Mobile Advertising
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Malawi
Liberia
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Costa Rica
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mauritius
Mozambique
Namibia
Nicaragua
Panama
Uzbekistan
Serbia
New Zealand
Australia
Morocco
Saudi Arabia
Guatemala
Sri Lanka
Jamaica
Kazakhstan
Switzerland
Venezuela
Cayman Islands
Myanmar
Turkey
Uruguay
Uganda
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Iraq
Ghana
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
El Salvador
Senegal
Sierra Leone
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Barbados
Belgium
Angola
Cyprus
Jordan
Azerbaijan
Ethiopia
Austria
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Ecuador
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Grenada
Finland
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Momi Karako invest in?

Momi Karako invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Post-IPO Debt and Debt Financing stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Momi Karako?

Public channels for Momi Karako include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Momi Karako last invest?

The most recent investment recorded for Momi Karako closed in Oct 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Momi Karako Find email